Implementation Strategies for Self-Measured Blood Pressure Monitoring in Racially and Ethnically Diverse Populations

Summary

This clinical trial aims to assess the impact of patient-focused and clinical-focused implementation strategies on blood pressure control. The investigators will assess the costs of these strategies and how effective they were at safely and equitably increasing home blood pressure monitoring.

Conditions

• Blood Pressure Monitoring, Home
• Hypertension

Interventions

BEHAVIORAL

BP monitor use training and app training

Patients will be taught how to use a BP monitor, along with the accompanying mobile app to view their readings.

BEHAVIORAL

Online patient portal enrollment and training

Patients will receive training on how to use an online patient portal. If they are not yet enrolled in an online patient portal and would like to be, they will also be enrolled into one.

BEHAVIORAL

SMS reminders to take blood pressure

Patients will receive reminders via SMS to take their blood pressure.

BEHAVIORAL

Education about self-management of hypertension

One-time training with action planning, access to website with language concordant patient education, and educational text messages

BEHAVIORAL

Educational text messages that encourage seeking support from a support person

Educational text messages about behavioral changes that explicitly encourage seeking support from a support person

BEHAVIORAL

Involvement of caregiver or support person

Patients will be asked to involve a caregiver or support person for all activities above, including patient portal proxy access.

BEHAVIORAL

Group classes

Patients will be asked to attend in-person or online group education classes on hypertension management

Sponsors & Collaborators

• University of California, Davis

  collaborator OTHER

• Beth Israel Deaconess Medical Center

  collaborator OTHER

• Agency for Healthcare Research and Quality (AHRQ)

  collaborator FED

• University of California, San Francisco

  lead OTHER

Principal Investigators

• Elaine Khoong, MD, MS · University of California, San Francisco

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-05-01

Primary Completion

2027-11-01

Completion

2028-05-01

Countries

• United States

Study Locations